Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Free Report) have been assigned an average rating of “Reduce” from the fifteen brokerages that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $14.73.
WBA has been the subject of several recent analyst reports. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Bank of America decreased their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research note on Friday, June 28th. Evercore ISI reduced their target price on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research report on Friday, June 28th. Finally, TD Cowen dropped their price objective on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th.
Check Out Our Latest Research Report on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Down 3.0 %
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.05). The business had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same period last year, the company earned $1.00 EPS. On average, research analysts anticipate that Walgreens Boots Alliance will post 2.86 earnings per share for the current year.
Walgreens Boots Alliance Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were given a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.48%. Walgreens Boots Alliance’s dividend payout ratio is -14.84%.
Hedge Funds Weigh In On Walgreens Boots Alliance
A number of hedge funds and other institutional investors have recently made changes to their positions in WBA. Pineridge Advisors LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter worth $26,000. Quest Partners LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth about $30,000. 1832 Asset Management L.P. raised its position in Walgreens Boots Alliance by 282.1% in the 4th quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 900 shares during the last quarter. New Covenant Trust Company N.A. bought a new stake in Walgreens Boots Alliance in the 1st quarter valued at approximately $35,000. Finally, First Personal Financial Services boosted its position in Walgreens Boots Alliance by 260.0% during the 1st quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator’s stock worth $39,000 after acquiring an additional 1,300 shares during the last quarter. 58.59% of the stock is owned by institutional investors.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- Dividend Capture Strategy: What You Need to Know
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What Are Dividend Contenders? Investing in Dividend Contenders
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Consumer Staples Stocks, Explained
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.